(Q37251057)

19 August 2017

1 reference

title

Immune modulation and chronic graft-versus-host disease (English)

1 reference

19 August 2017

Rj Soiffer

1

1 reference

PubMed ID

18724307

19 August 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

Bone Marrow Transplantation

19 August 2017

1 reference

19 August 2017

42 Suppl 1

1 reference

19 August 2017

S66-S69

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2008.119

19 August 2017

0 references

cites work

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Quality of life associated with acute and chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Optimistic expectations and survival after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Pentostatin for the treatment of chronic graft-versus-host disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Potential mechanisms of photopheresis in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

A function for interleukin 2 in Foxp3-expressing regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

High levels of B-cell activating factor in patients with active chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Rituximab for steroid-refractory chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.119

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.119

1 reference

PubMed ID

18724307

Dimensions Publication ID

19 August 2017

0 references

1 reference

PubMed ID

18724307